## Overview of Abdominal Aortic Aneurysm (AAA) Without Rupture (I71.4) An abdominal aortic aneurysm (AAA) is a localized dilation of the abdominal aorta, the main blood vessel supplying blood to the body, to at least 1.5 times its normal diameter, typically defined as greater than or equal to 3.0 cm. The ICD-10 code I71.4 specifically refers to an abdominal aortic aneurysm that has not ruptured, representing a significant but often silent cardiovascular condition. ### Pathophysiology The development of an AAA is a complex process primarily driven by atherosclerosis, chronic inflammation, and proteolytic degradation of the aortic wall. The aorta's wall is composed of three layers: the intima, media, and adventitia. The media, rich in elastin and smooth muscle cells, provides structural integrity. In AAA formation, there is a progressive weakening and degeneration of the elastin and collagen within the media, accompanied by a chronic inflammatory infiltrate involving macrophages and lymphocytes. These inflammatory cells release various proteolytic enzymes, particularly matrix metalloproteinases (MMPs), which actively degrade the extracellular matrix components, leading to loss of elasticity and structural integrity. This weakening, combined with the continuous pulsatile pressure from blood flow, causes the arterial wall to progressively dilate. Risk factors such as smoking, hypertension, and hyperlipidemia accelerate this process by promoting oxidative stress and endothelial dysfunction, further exacerbating the inflammatory and degenerative cascades. As the aneurysm expands, wall tension increases according to Laplace's law (tension = pressure x radius), further promoting dilation and increasing the risk of rupture. ### Clinical Presentation Most AAAs are asymptomatic and are often discovered incidentally during imaging studies performed for other reasons (e.g., ultrasound, CT scan of the abdomen). When symptoms do occur, they may be vague and non-specific. The most common presentation is a pulsatile mass in the abdomen, which may be palpable during a physical examination, especially in leaner individuals. Patients might experience abdominal pain, often described as a deep, steady, gnawing ache that can radiate to the back, flank, or groin. This pain can indicate rapid expansion of the aneurysm or impending rupture, even in the absence of a full rupture. Rarely, an AAA can lead to peripheral embolization if mural thrombus fragments dislodge and travel downstream, causing acute limb ischemia. Other rare symptoms include early satiety or weight loss if the aneurysm compresses gastrointestinal structures. ### Diagnostic Criteria Diagnosis of AAA primarily relies on imaging. Physical examination may reveal a pulsatile abdominal mass, but its sensitivity is limited, particularly in obese patients. The primary diagnostic tools include: * **Abdominal Ultrasound**: This is the most common and cost-effective screening tool. It provides accurate measurements of aortic diameter and can easily identify the presence and size of an aneurysm. It is excellent for surveillance. * **Computed Tomography Angiography (CTA)**: Considered the gold standard for definitive diagnosis, precise sizing, and detailed anatomical assessment. CTA provides high-resolution images that define the aneurysm's diameter, length, presence of mural thrombus, relationship to renal arteries, and suitability for repair. It is crucial for pre-operative planning. * **Magnetic Resonance Angiography (MRA)**: An alternative to CTA, particularly useful for patients with renal insufficiency or contrast dye allergies. It also provides detailed anatomical information but is typically more time-consuming and expensive. ### Standard of Care The management of an unruptured AAA depends largely on its size, growth rate, and the patient's overall health. The primary goals are to prevent rupture and manage associated comorbidities. * **Surveillance**: For smaller aneurysms (generally less than 5.5 cm in men and 5.0 cm in women, or without rapid expansion defined as <0.5 cm in 6 months), watchful waiting with regular ultrasound monitoring is the standard of care. The frequency of surveillance depends on the aneurysm's size, typically every 6-12 months. * **Risk Factor Modification**: Aggressive management of cardiovascular risk factors is paramount. This includes strict blood pressure control (antihypertensives), smoking cessation (the most important modifiable risk factor), statin therapy for hyperlipidemia, and antiplatelet agents. Lifestyle modifications such as regular exercise and a healthy diet are also encouraged. * **Elective Repair**: Intervention is generally recommended for aneurysms that reach a threshold size (typically 5.5 cm in men, 5.0 cm in women, or rapid expansion >0.5 cm in 6 months), become symptomatic (indicating impending rupture or compression of adjacent structures), or are associated with peripheral embolization. There are two main types of repair: * **Open Surgical Repair (OSR)**: Involves a laparotomy, clamping the aorta, incising the aneurysm sac, and replacing the diseased segment with a synthetic graft. This is a durable procedure but is more invasive with a longer recovery period. * **Endovascular Aneurysm Repair (EVAR)**: A less invasive technique where a stent-graft is deployed within the aneurysm via catheters inserted through the femoral arteries. EVAR is associated with shorter hospital stays, less pain, and quicker recovery, making it suitable for many patients. However, it requires lifelong surveillance to monitor for complications such as endoleaks or device migration. The choice between OSR and EVAR depends on aneurysm morphology, patient comorbidities, and surgeon expertise.